2021
Twelve-Month Retention in Opioid Agonist Treatment for Opioid Use Disorder Among Patients With and Without HIV
Wyse JJ, McGinnis KA, Edelman EJ, Gordon AJ, Manhapra A, Fiellin DA, Moore BA, Korthuis PT, Kennedy AJ, Oldfield BJ, Gaither JR, Gordon KS, Skanderson M, Barry DT, Bryant K, Crystal S, Justice AC, Kraemer KL. Twelve-Month Retention in Opioid Agonist Treatment for Opioid Use Disorder Among Patients With and Without HIV. AIDS And Behavior 2021, 26: 975-985. PMID: 34495424, PMCID: PMC8840957, DOI: 10.1007/s10461-021-03452-0.Peer-Reviewed Original ResearchConceptsOpioid agonist therapyOpioid use disorderVeterans Aging Cohort StudyHIV statusUse disordersOpioid agonist treatmentAging Cohort StudyDiagnosis of HCVTwelve-month retentionPositive health outcomesOAT retentionAgonist therapyCohort studyHIV managementAgonist treatmentPredictors of retentionPatientsHealth outcomesHistory of homelessnessHIVLower likelihoodImproved likelihoodLikelihood of initiationBuprenorphineDisorders
2016
The Availability of Ancillary Counseling in the Practices of Physicians Prescribing Buprenorphine
Barry DT, Fazzino T, Necrason E, Ginn J, Fiellin LE, Fiellin DA, Moore BA. The Availability of Ancillary Counseling in the Practices of Physicians Prescribing Buprenorphine. Journal Of Addiction Medicine 2016, 10: 352-356. PMID: 27504926, PMCID: PMC5042831, DOI: 10.1097/adm.0000000000000247.Peer-Reviewed Original ResearchConceptsBuprenorphine treatmentAddiction medicine providersOpioid agonist treatmentOpioid-dependent patientsOpioid use disorderPractices of physiciansSelf-help groupsAgonist treatmentDependent patientsPhysicians' perceptionsPhysicians' attitudesMedicine providersUse disordersE-mail invitationSuch counselingProvider specializationAddiction medicinePatientsDrug abuseCounseling requirementsIndividual counselingStudy sampleFamily medicineNational InstituteCounseling